Judith M. Matthews - Mar 11, 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Signature
/s/ Judith M. Matthews
Stock symbol
ITRM
Transactions as of
Mar 11, 2023
Transactions value $
-$2,768
Form type
4
Date filed
3/14/2023, 06:00 PM
Previous filing
Mar 15, 2022
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Award $0 +6.67K +153.17% $0.00 11K Mar 11, 2023 Direct F1, F2
transaction ITRM Ordinary Shares Tax liability -$2.77K -2.88K -26.17% $0.96 8.14K Mar 11, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -6.67K -100% $0.00* 0 Mar 11, 2023 Ordinary Shares 6.67K Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
F3 Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
F4 On March 11, 2021, the reporting person was granted an award of 13,333 RSUs, 50% of which vested on March 11, 2022, with the remaining 50% having vested on March 11, 2023.